Eric Turowski

Eric Turowski, MBA, is an enterprise market access and commercial strategy leader with over 15 years of experience in shaping payer access, pricing, and distribution strategies across oncology and specialty portfolios. They have held prominent roles at esteemed organizations, including Eli Lilly and Company, Chimerix, Inc., and Jazz Pharmaceuticals, driving successful product launches and corporate transformations. Currently, they serve as Vice President of Market Access for the Oncology Franchise at Jazz Pharmaceuticals, where they continue to leverage their expertise in market access and patient services. Eric is an alumnus of Duke University, where they earned an MBA as a Fuqua Scholar, and they also hold a Bachelor of Business Administration from Western Michigan University.